Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Prostate Cancer
Interventions
RADIATION

Radiotherapy 70 Gy

Radiotherapy to the prostate

RADIATION

Radiotherapy 76 Gy

Radiotherapy to the prostate

DRUG

Androgen blockade

Duration : 6 months

Trial Locations (1)

J1H 5N4

Centre de Recherche Clinique du CHUS, Sherbrooke

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Abdenour Nabid

OTHER